- Rainbow Children’s Medicare Limited (NSE: RAINBOW | BSE: 543524) announced a definitive transaction to build a new children’s and women’s hospital in Malad, Mumbai, with an estimated cost of ≈ ₹90 Crore.
- The project will be executed through its wholly‑owned subsidiary Rainbow Women & Children’s Hospital Private Limited (RWCHPL); Fountainhead TCHM Healthcare LLP will acquire a 24 % equity stake, while Rainbow Children’s Medicare Limited retains 76 % control.
- After the deal, RWCHPL will shift from a wholly‑owned to a 76 %‑owned subsidiary, preserving Rainbow’s majority ownership of the new facility.
- The filing satisfies Regulation 30 read with Schedule III of the SEBI Listing Regulations, with full details in Annexures A‑C and on the company’s investor‑relations portal.
- The expansion adds a Mumbai foothold to Rainbow’s existing network across major Indian cities and brings in Fountainhead’s clinical expertise to boost service quality.
Rainbow’s plan to add a Mumbai hospital and sell a 24% stake is likely to be seen as a modest growth boost, nudging the share price higher. The move is modest relative to its size, so investors may react positively but not dramatically.
Sign in for impact outlook, horizons, comparables, and full intelligence analysis.
Forecast from comparable, historic events. Not investment advice.
Frism is a financial information and news discovery platform. We provide factual summaries and data correlations for educational and informational purposes only. Frism does not provide investment advice, buy/sell recommendations, or directional market outlooks. Users should consult a qualified financial advisor before making any investment decisions.
Frism Computing (OPC) Private Limited
#74, 15TH CROSS, JP Nagar III Phase, Bangalore South, Bangalore 560078, Karnataka